Skip to content

Expert Opinion on Drug Discovery, 2017

Stabilized helical peptides: overview of the technologies and its impact on drug discovery

View Publication

Cold Spring Harbor Perspectives in Medicine, 2017

Exploiting the p53 Pathway for Therapy

View Publication

Nature Reviews Immunology, 2016

Emerging roles of p53 and other tumour-suppressor genes

View Publication

Coldspring Harbor Perspectives in Medicine, 2016

MDMX (MDM4), a Promising Target for p53 Reactivation Therapy and Beyond

View Publication

Annual Reports in Medicinal Chemistry, 2014

Advancements in Stapled Peptide Drug Discovery & Development

View Article

Royal Society of Chemistry, Macrocycles in Drug Discovery, 2014

Chapter 9: Macrocyclic α-helical peptide drug discovery

View Chapter

Proceedings of the National Academy of Sciences (PNAS), 2013

Stapled α-helical peptide drug development: A potent dual inhibitor of MDM2 and MDMX for p53-dependent cancer therapy

View Publication

Nature Reviews Clinical Oncology, 2011

Translating p53 into the clinic

View Publication

Interested in partnering with Aileron?
Please contact us.